Adrian V. Lee
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (11)
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
As one of the most successful cancer therapeutic targets, estrogen receptor-α (ER/ESR1) has been extensively studied over the past few decades. Sequencing technological advances have enabled genome-wide analysis of ER action. However, comparison of individual studies is limited by different experimental designs, and few meta-analyses are available. Here, we established the EstroGene database through unified processing of data from 246 experiments including 136 transcriptomic, cistromic, and epigenetic datasets focusing on estradiol (E2)-triggered ER activation across 19 breast cancer cell lines. A user-friendly browser (https://estrogene.org/) was generated for multiomic data visualization involving gene inquiry under user-defined experimental conditions and statistical thresholds. Notably, annotation of metadata associated with public datasets revealed a considerable lack of experimental details. Comparison of independent RNA-seq or ER ChIP-seq data with the same design showed large variability and only strong effects could be consistently detected. Temporal estrogen response metasignatures were defined, and the association of E2 response rate with temporal transcriptional factors, chromatin accessibility, and heterogeneity of ER expression was evaluated. Unexpectedly, harmonizing 146 E2-induced transcriptomic datasets uncovered a subset of genes harboring bidirectional E2 regulation, which was linked to unique transcriptional factors and highly associated with immune surveillance in the clinical setting. Furthermore, the context dependent E2 response programs were characterized in MCF7 and T47D cell lines, the two most frequently used models in the EstroGene database. Collectively, the EstroGene database provides an informative and practical resource to the cancer research community to uniformly evaluate key reproducible features of ER regulomes and unravels modes of ER signaling. Significance: A resource database integrating 246 publicly available ER profiling datasets facilitates meta-analyses and identifies estrogen response temporal signatures, a bidirectional program, and model-specific biases.
Year:
2023
Year:
2023
Year:
2022
Collaborators (13)
Osama Shiraz Shah
University of Nebraska Medical Center
Christos Sotiriou
Université libre de Bruxelles
Stefanie Böhm
Max Planck Institute of Biophysics
Stewart Anderson
Professor
University of Pittsburgh
Charles Edward Geyer Jr
Professor of Medicine in Division of Hematology/Medical Oncology
University of Pittsburgh
Marija Balic
Section chief for Medical Breast Oncology
University of Pittsburgh Medical Center
Jeffrey Fine
Assistant Professor
University of Pittsburgh School of Medicine
Atilla Soran
University of Pittsburgh School of Medicine
Yu-Chiao Chiu
Assistant Professor
University of Pittsburgh
Qiqi Ye
Cooper University Hospital
Peter Lucas
Professor and Vice Chair
University of Pittsburgh School of Medicine
Rita A. Mukhtar
University of California
Neil Carleton
University of Pittsburgh
Make your next move.
Prepare your application
Review drafts before you send them.